Patents by Inventor Sibrand Poppema

Sibrand Poppema has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inducing IL-10 production
    Patent number: 7919097
    Abstract: The invention provides a method of inducing IL-10 production.
    Type: Grant
    Filed: October 15, 2009
    Date of Patent: April 5, 2011
    Assignee: IQ Corporation BV
    Inventors: Herman Groen, Sibrand Poppema, Anke van den Berg, Lydia Visser, Judith van der Leij, Rob P. van Weeghel, Peter Zwiers
  • Methods of inducing IL-10 production
    Patent number: 7700105
    Abstract: The invention provides a method of inducing IL-10 production.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: April 20, 2010
    Assignee: IQ Corporation BV
    Inventors: Herman Groen, Sibrand Poppema, Anke ven den Berg, Lydia Visser, Judith van der Leij, Rob P. van Weeghel, Peter Zwiers
  • METHODS OF INDUCING IL-10 PRODUCTION
    Publication number: 20100040639
    Abstract: The invention provides a method of inducing IL-10 production.
    Type: Application
    Filed: October 15, 2009
    Publication date: February 18, 2010
    Applicant: IQ CORPORATION BV
    Inventors: Herman Groen, Sibrand Poppema, Anke van den Berg, Lydia Visser, Judith van der Leij, Rob P. van Weeghel, Peter Zwiers
  • Methods of inducing IL-10 production
    Publication number: 20080019987
    Abstract: The invention provides a method of inducing IL-10 production
    Type: Application
    Filed: January 8, 2007
    Publication date: January 24, 2008
    Inventors: Herman Groen, Sibrand Poppema, Anke Berg, Lydia Visser, Judith Leij, Rob Weeghel, Peter Zwiers
  • Methods of inducing IL-10 production
    Patent number: 7160861
    Abstract: The invention provides a method of inducing IL-10 production.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: January 9, 2007
    Assignee: IQ Corporation BV
    Inventors: Herman Groen, Sibrand Poppema, Anke van den Berg, Lydia Visser, Judith van der Leij, Rob P. van Weeghel, Peter Zwiers
  • Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
    Patent number: 7160987
    Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: January 9, 2007
    Assignee: Alimunne, L.L.C.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema
  • Methods of inducing IL-10 production
    Publication number: 20050215465
    Abstract: The invention provides a method of inducing IL-10 production
    Type: Application
    Filed: December 13, 2004
    Publication date: September 29, 2005
    Inventors: Herman Groen, Sibrand Poppema, Anke Berg, Lydia Visser, Judith Leij, Rob Weeghel, Peter Zwiers
  • Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
    Publication number: 20020168362
    Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
    Type: Application
    Filed: March 19, 2002
    Publication date: November 14, 2002
    Applicant: Alimmune, L.L.C., Research Corporation Technologies, Inc.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema
  • Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
    Patent number: 6379668
    Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: April 30, 2002
    Assignees: Research Corporation Technologies, Inc., Alimmune, LLC
    Inventors: Andrew I. Lazarovits, Sibrand Poppema
  • Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
    Patent number: 6106834
    Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
    Type: Grant
    Filed: September 18, 1996
    Date of Patent: August 22, 2000
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema
  • Pharmaceutical compositions comprising anti-CD45RB antibodies for the inhibition of T-cell mediated immune responses
    Patent number: 6099838
    Abstract: Compositions comprising anti-CD45RB antibodies are provided for the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases.
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: August 8, 2000
    Assignee: Reasearch Corporation Technologies, Inc.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema
  • Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
    Patent number: 6024957
    Abstract: Compounds and methods are described for the differential inhibition of tyrosine phosphorylation of phospholipase C-.gamma.1 for the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases. Methods for the treating or preventing tissue or organ transplant rejection and methods for treating an autoimmune disease comprising the administration of monoclonal antibodies that specifically bind to the CD45RB epitope of the CD45RB isoform are disclosed.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: February 15, 2000
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema